The FDA under former President Joe Biden last summer declined to allow MDMA, also known as ecstasy, to be used as a treatment for PTSD citing a lack of evidence that it was both safe and effective.

With UCI and other programs, psychedelics soon could be as controversial as aspirin Schools are about to start teaching how to turn party drugs into non-party drugs. For millions, that could be a ...

Also, the specific drug in question had performed well in Stage 3 clinical trials (usually the last step before FDA approval), with 2 out of 3 MDMA recipients considered cured of PTSD after two ...

Also, the specific drug in question had performed well in Stage 3 clinical trials (usually the last step before FDA approval), with 2 out of 3 MDMA recipients considered cured of PTSD after two months ...

It looks like Biogen Inc.’s Nrf2 activator, Skyclarys (omaveloxolone), will maintain its status as the sole therapy approved for treating patients with Friedreich’s ataxia (FA), at least for now. The ...

enVVeno Medical (NVNO) stock plunges as the FDA rejects VenoValve approval over efficacy and safety concerns. Read more here.

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday.

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children younger than 5 years old, a move that would add another barrier ...

Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP)Papzimeos, the first-ever treatment approved for RRP is a moment for celebration and reflection ...

The FDA has approved a treatment for recurrent respiratory papillomatosis for the first time, signing off on Precigen’s immunotherapy Papzimeos.

The FDA granted approval to brensocatib for treating adults and children aged at least 12 years with non-cystic fibrosis bronchiectasis, marking the first treatment approved for this indication ...